TIME COURSE OF THE DEVELOPMENT OF IMMUNOTHROMBOSIS DURING COVID-19 HOSPITALIZATION

TIME COURSE OF THE DEVELOPMENT OF IMMUNOTHROMBOSIS DURING COVID-19 HOSPITALIZATION

Introduction: Hypercoagulability in COVID-19 has been attributed to immunothrombosis, a process that involves the formation of neutrophils extracellular traps (NETs). The moment of the COVID-19 evolution in which immunothrombosis mechanisms are triggered is not established. Aim: To describe the kine...

Full description

Bibliographic Details
Main Authors:	JD Oliveira, BMM Fonseca, CO Vaz, KHO Soares, JCS Mariolano, GA Locachevic, GV Damiani, EV Paula, FA Orsi
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137921010397

Similar Items

DIAGNÓSTICO DA COVID-19 E SEU IMPACTO SOBRE O RISCO TROMBÓTICO EM UMA COORTE DE PACIENTES SIMULTANEAMENTE HOSPITALIZADOS POR SÍNDROME RESPIRATÓRIA AGUDA GRAVE
by: A Coy-Canguçu, et al.
Published: (2021-10-01)

Immunothrombosis and its underlying biological mechanisms
by: Arthur Cunha De Nardi, et al.
Published: (2024-01-01)

Editorial: Molecular drivers of immunothrombosis
by: Alice Assinger, et al.
Published: (2024-02-01)

Endothelial dysfunction and immunothrombosis in sepsis
by: Eleni Maneta, et al.
Published: (2023-04-01)

Immunothrombosis in severe COVID-19
by: Daigo Nakazawa, et al.
Published: (2020-09-01)

Chemokines, molecular drivers of thromboinflammation and immunothrombosis
by: Julian Leberzammer, et al.
Published: (2023-10-01)

Immunothrombosis and thromboinflammation in host defense and disease
by: Kimberly Martinod, et al.
Published: (2021-04-01)

The role of megakaryocytes and platelets in infection and immunothrombosis
by: Frydman, Galit Hocsman
Published: (2018)

Mechanisms of Immunothrombosis by SARS-CoV-2
by: María Teresa Hernández-Huerta, et al.
Published: (2021-10-01)

Neutrophil extracellular traps mediate neuro-immunothrombosis
by: Jianbo Lou, et al.
Published: (2024-01-01)

Evolutionary Insight into Immunothrombosis as a Healing Mechanism
by: Eduardo Anitua, et al.
Published: (2022-07-01)

Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases
by: Marco Heestermans, et al.
Published: (2022-10-01)

Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
by: Maria Ascencion Globisch, et al.
Published: (2022-10-01)

Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives
by: María Marcos-Jubilar, et al.
Published: (2023-02-01)

C-reactive protein, immunothrombosis and venous thromboembolism
by: Caroline Dix, et al.
Published: (2022-09-01)

Immunothrombosis in Acute Respiratory Dysfunction of COVID-19
by: Xiang-Zhi Fang, et al.
Published: (2021-06-01)

Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps
by: Brandon Bautista-Becerril, et al.
Published: (2021-05-01)

Extracellular DNA—A Danger Signal Triggering Immunothrombosis
by: Chongxu Shi, et al.
Published: (2020-10-01)

COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response
by: Apoorva Jayarangaiah MD, et al.
Published: (2020-07-01)

EVALUATION OF A GENE SIGNATURE RELATED TO THROMBOTIC MANIFESTATIONS IN ANTIPHOSPHOLIPID SYNDROME
by: BC Jacintho, et al.
Published: (2021-10-01)

The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review
by: Ira Glassman, et al.
Published: (2023-03-01)

Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option
by: Julie Helms, et al.
Published: (2023-06-01)

Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond
by: Alpo Vuorio, et al.
Published: (2021-01-01)

Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19
by: Tiphaine Ruggeri, et al.
Published: (2023-11-01)

PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis
by: Willie Elliott, et al.
Published: (2021-12-01)

Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation
by: Hidenori Wake, et al.
Published: (2016-07-01)

Hepatic Surgical Stress Promotes Systemic Immunothrombosis That Results in Distant Organ Injury
by: Hongji Zhang, et al.
Published: (2020-05-01)

ATIVIDADE DAS CÉLULAS DENDRÍTICAS PLASMOCITÓIDES EM PORTADORES DE ANTIFOSFOLIPÍDES ASSINTOMÁTICOS E NA SÍNDROME ANTIFOSFOLIPÍDE PRIMÁRIA E SECUNDÁRIA COM TROMBOSE
by: APRD Santos, et al.
Published: (2021-10-01)

Early Postoperative Immunothrombosis of Bioprosthetic Mitral Valve and Left Atrium: A Case Report
by: Alexander Kostyunin, et al.
Published: (2022-06-01)

Activated Platelets and Platelet-Derived Extracellular Vesicles Mediate COVID-19-Associated Immunothrombosis
by: Marie Ebeyer-Masotta, et al.
Published: (2022-07-01)

Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis
by: Jarbas da Silva Motta Junior, et al.
Published: (2020-09-01)

Evaluation of Glutathione in Spike Protein of SARS-CoV-2 Induced Immunothrombosis and Cytokine Dysregulation
by: Brandon Norris, et al.
Published: (2024-02-01)

Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor
by: E. V. Slukhanchuk, et al.
Published: (2023-01-01)

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13
by: Junxian Yang, et al.
Published: (2020-12-01)

Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection
by: Ivo M.B. Francischetti, et al.
Published: (2021-09-01)

Neutrophil extracellular traps contribute to immunothrombosis formation via the STING pathway in sepsis-associated lung injury
by: Shuainan Zhu, et al.
Published: (2023-08-01)

Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis
by: Teppei Hashimoto, et al.
Published: (2022-01-01)

NEUTROPHIL EXTRACELLULAR TRAPS E COVID-19
by: APH Yokoyama, et al.
Published: (2021-10-01)

Inhibition of immunothrombosis does not affect pathogen capture and does not promote bacterial dissemination in a mouse model of sepsis
by: Agostina Carestia, et al.
Published: (2020-10-01)

Thrombosis Occurrence in COVID-19 Compared With Other Infectious Causes of ARDS: A Contemporary Cohort
by: Andréa Coy-Canguçu, et al.
Published: (2023-05-01)